title: Why innovation in inflammatory bowel disease drug development will impact your practice.
authors.affiliation: Division of Gastroenterology, University of California San Diego, La Jolla, California 92093-0063, USA. wsandborn@ucsd.edu
authors.forename: William J
authors.initials: WJ
authors.lastname: Sandborn
mesh_terms: D001688:Biological Products / Q000191:economics / Q000302:isolation & purification / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D055808:Drug Discovery / Q000639:trends*; D004359:Drug Therapy, Combination / Q000379:methods; D005765:Gastrointestinal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D001688:Biological Products; D015415:Biomarkers; D005765:Gastrointestinal Agents